An FDA advisory committee is evaluating ways to make the toughest risk evaluation and mitigation strategies more effective and less burdensome.The Senate unanimously approved an amendment to the National Defense Authorization Act that would fund Small Business Innovation and Research and Small Business Technology Transfer through fiscal 2019.